Gilead Sciences To Acquire Cell Therapy Company in $567-Million Deal
By
Gilead Sciences and its cell-therapy subsidiary, Kite Pharma, have agreed to acquire Cell Design Labs, an Emeryville, California-headquartered company specializing in cell therapies and related technologies, for $567 million. The…